Wells Fargo’s TuHURA Biosciences HURA Stock Holding History

Wells Fargo’s Portfolio HURA Stock Details HURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$31.2K	Sell	17,444 -20,764	-54%	-$25.4K	﹤0.01%	5614
2025 Q4	$28.9K	Buy	38,208 +19,931	+109%	+$38.1K	﹤0.01%	5693
2025 Q3	$45.3K	Buy	18,277 +3,202	+21%	+$8.43K	﹤0.01%	5580
2025 Q2	$33.6K	Buy	15,075 +13,275	+738%	+$44.9K	﹤0.01%	5645
2025 Q1	$5.81K	Hold	1,800	–	–	﹤0.01%	6001
2024 Q4	$7.36K	Buy	1,800 +1,754	+3,813%	+$9.32K	﹤0.01%	5994
2024 Q3	$315	Buy	+46	New	+$342	﹤0.01%	6204
2024 Q2	–	Sell	-1	Closed	-$3	–	7568
2024 Q1	$3	Buy	+1	New	+$4	﹤0.01%	7440
2023 Q4	–	Hold	0	–	–	–	7549
2023 Q3	–	Hold	0	–	–	–	6930
2023 Q2	–	Hold	0	–	–	–	7067
2023 Q1	–	Hold	0	–	–	–	7182
2022 Q4	–	Hold	0	–	–	–	6865
2022 Q3	–	Hold	0	–	–	–	7531
2022 Q2	–	Hold	0	–	–	–	7654
2022 Q1	–	Hold	0	–	–	–	7985
2021 Q4	–	Hold	0	–	–	–	7936
2021 Q3	–	Hold	0	–	–	–	7638
2021 Q2	–	Hold	0	–	–	–	7573
2021 Q1	–	Hold	0	–	–	–	7499
2020 Q4	–	Hold	0	–	–	–	7133
2020 Q3	–	Hold	0	–	–	–	7028

Other funds holding HURA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AWM

Apollon Wealth Management Mount Pleasant, South Carolina $6.15B AUM 22.62% 1-Year Est. Return

Wells Fargo's HURA Position: Q1 2026 in Review

Wells Fargo reduced its TuHURA Biosciences (HURA) stake by 54% in Q1 2026, selling an estimated $25.4K and leaving 17,444 shares worth $31.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5614.

Wells Fargo first reported a position in HURA in Q1 2024 and has held it in 8 quarters since. The position peaked at $45.3K in Q3 2025. 89 funds tracked by Wall St. Rank hold HURA as of Q1 2026.

Wells Fargo held 17,444 shares of TuHURA Biosciences worth $31.2K as of Q1 2026.
Wells Fargo sold 20,764 TuHURA Biosciences shares in Q1 2026, an estimated $25.4K.
TuHURA Biosciences made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5614 holding.
Wells Fargo first reported a position in TuHURA Biosciences in Q1 2024 and has held it in 8 quarters since.
Wells Fargo's TuHURA Biosciences position peaked at $45.3K in Q3 2025.
89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.